US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BioStem Technologies, Inc.

3.68

+0.15004.25%

Post-market: 3.65-0.0300-0.82%17:17 EDT

Volume:196.38K

Turnover:738.75K

Market Cap:65.62M

PE:-2.20

High:4.05

Open:3.50

Low:3.50

Close:3.53

52wk High:8.40

52wk Low:2.25

Shares:17.83M

Float Shares:14.04M

Volume Ratio:3.01

T/O Rate:1.40%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.6713

EPS(LYR):-0.3934

ROE:-74.74%

ROA:-18.07%

PB:2.38

PE(LYR):-9.35

Loading ...

Overview Company News Filings

BioStem Files Form 3 for Chief Accounting Officer Michael Fortunato

BioStem Technologies to Present at Sidoti MicroCap Virtual Conference

BioStem Technologies, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

BioStem Technologies Q2 EPS $(0.52), Sales $7.899M Down From $10.963M YoY

Benzinga Earnings

BioStem Q2 FY26 GAAP Net Loss Widens to $9 Million; Revenue Rises 29% to $7.9 Million vs Q1

Press Release: BioStem Technologies Reports Second Quarter 2026 Financial Results

BioStem Technologies to Begin Trading on NASDAQ Capital Market Aug. 7 Under BSEM Ticker

Biostem Technologies Announces NASDAQ Uplisting

THOMSON REUTERS

Biostem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission

THOMSON REUTERS

Biostem Technologies - Shares to Continue Trading on Otc Under 'bsem' Until NASDAQ Uplisting

THOMSON REUTERS

BioStem Technologies issued four U.S. design patents for allograft technology

BRIEF-Biostem Technologies Announces Appointment Of Three New Members To Its Board Of Directors

Press Release: BioStem Technologies Announces Appointment of Three New Members to its Board of Directors

Biostem Technologies Announces Appointment of Three New Members to Its Board of Directors

THOMSON REUTERS

Biostem Technologies Announces $2.5 Million Private Placement Financing With Its First Institutional Investor

THOMSON REUTERS

BioStem Technologies price target lowered to $7 from $9 at H.C. Wainwright

Press Release: BioStem Technologies Reports First Quarter 2026 Financial Results

BioStem Technologies Q1 revenue falls 62% yr/yr

Biostem Technologies, Inc. Q1 EPS USD -0.52

THOMSON REUTERS

Biostem Technologies initiated with a Buy at H.C. Wainwright

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/BSEM/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BSEM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BSEM\",,,,,undefined,":{"symbol":"BSEM","market":"US","secType":"STK","nameCN":"BioStem Technologies, Inc.","latestPrice":3.68,"timestamp":1788206400000,"preClose":3.53,"halted":0,"volume":196382,"hourTrading":{"tag":"盘后","latestPrice":3.65,"preClose":3.68,"latestTime":"17:17 EDT","volume":457,"amount":1697.8720833999998,"timestamp":1788211049416,"change":-0.03,"changeRate":-0.008152,"amplitude":0.040761},"delay":0,"changeRate":0.0424929178470256,"floatShares":14042148,"shares":17831900,"eps":-1.671347,"marketStatus":"Post-Mkt","change":0.15,"latestTime":"08-31 17:27:01 EDT","open":3.5,"high":4.0499,"low":3.5,"amount":738750.7109572,"amplitude":0.155779,"askPrice":3.93,"askSize":100,"bidPrice":3.6,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-1.671347,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":3.53,"preHourTrading":{"tag":"盘前","latestPrice":3.51,"preClose":3.53,"latestTime":"09:29 EDT","volume":1736,"amount":6510.038192,"timestamp":1788182957075,"change":-0.02,"changeRate":-0.005666,"amplitude":0.096884},"postHourTrading":{"tag":"盘后","latestPrice":3.65,"preClose":3.68,"latestTime":"17:17 EDT","volume":457,"amount":1697.8720833999998,"timestamp":1788211049416,"change":-0.03,"changeRate":-0.008152,"amplitude":0.040761},"volumeRatio":3.009677},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BSEM\",,,,,undefined,":{"symbol":"BSEM","floatShares":14042148,"roa":"-18.07%","roe":"-74.74%","lyrEps":-0.393388,"volumeRatio":3.009677,"shares":17831900,"dividePrice":0,"high":4.0499,"amplitude":0.155779,"preClose":3.53,"low":3.5,"week52Low":2.251,"pbRate":"2.38","psRate":"1.90","week52High":8.4,"institutionHeld":0,"latestPrice":3.68,"committee":0.333333,"eps":-1.671347,"divideRate":0,"volume":196382,"delay":0,"ttmEps":-1.671347,"open":3.5,"prevYearClose":3.81,"prevWeekClose":3.53,"prevMonthClose":3.3142,"prevQuarterClose":3.3,"fiveDayClose":3.92,"twentyDayClose":3.12,"sixtyDayClose":4.0365},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BSEM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"BSEM","fiscalQuarterEnding":"2026/06","expectedEps":-0.5,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.52},{"date":"2026-05-14","symbol":"BSEM","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1778788800000,"name":null,"time":"Post-Mkt","dateTimestamp":1778731200000,"actualEps":null},{"date":"2026-03-24","symbol":"BSEM","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774339200000,"name":null,"time":"","dateTimestamp":1774324800000,"actualEps":null},{"date":"2025-11-13","symbol":"BSEM","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763024400000,"name":null,"time":"","dateTimestamp":1763010000000,"actualEps":null},{"date":"2025-08-14","symbol":"BSEM","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755158400000,"name":null,"time":"","dateTimestamp":1755144000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BSEM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BSEM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1778126400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BSEM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BSEM","date":"2026-08-28","current":-2.222758,"percent":0.4,"low":-3.757423,"twenty":-3.314185,"median":-2.362834,"eighty":-2.067302,"high":-1.892791,"avg":-2.581417,"sd":0.600175,"marketCap":68720463},"quantilePoints":[{"date":"2026-08-06","current":-3.060802,"twenty":-3.060802,"median":-3.060802,"eighty":-3.060802,"marketCap":59100221},{"date":"2026-08-14","current":-1.982708,"twenty":-3.488616,"median":-3.39222,"eighty":-3.060802,"marketCap":54952215},{"date":"2026-08-21","current":-2.321824,"twenty":-3.470255,"median":-2.321824,"eighty":-1.987431,"marketCap":65686053},{"date":"2026-08-28","current":-2.429082,"twenty":-3.314185,"median":-2.362834,"eighty":-2.067302,"marketCap":68720463}],"updateTime":1788193868533},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BSEM\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659226511","title":"BioStem Files Form 3 for Chief Accounting Officer Michael Fortunato","url":"https://stock-news.laohu8.com/highlight/detail?id=2659226511","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659226511?lang=en_us&edition=fundamental","pubTime":"2026-08-15 07:07","pubTimestamp":1786748870,"startTime":"0","endTime":"0","summary":"BioStem files Form 3 for Chief Accounting Officer Michael FortunatoBioStem named Michael A. Fortunato as chief accounting officer; Form 3 shows 63,460 common shares held directly as of Aug. 6, 2026.Di","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL5gDrgg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BSEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659126714","title":"BioStem Technologies to Present at Sidoti MicroCap Virtual Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2659126714","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659126714?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:06","pubTimestamp":1786738017,"startTime":"0","endTime":"0","summary":"BioStem Technologies to Present at Sidoti MicroCap Virtual ConferenceBioStem Technologies will present at the Sidoti MicroCap Virtual Conference on Aug. 19, 2026 at 10:45 a.m. ET.Disclaimer:This news ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL7r41Q2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","LU0314104364.USD","SG9999014021.USD","NDAQ","LU2095319765.USD","SG9999014039.USD","IE00B64PRP62.GBP","BK4007","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","LU2210149790.SGD","BK4588","BCDF","IE00BKPKM429.USD","BSEM","SG9999014013.SGD","SG9999014005.SGD","BK4585","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659819678","title":"BioStem Technologies, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659819678","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659819678?lang=en_us&edition=fundamental","pubTime":"2026-08-14 08:35","pubTimestamp":1786667722,"startTime":"0","endTime":"0","summary":"BioStem Technologies, Inc. reports results for the quarter ended June 30 - Earnings SummaryBioStem Technologies, Inc. <> reported a quarterly adjusted loss of 52 cents per share for the quarter ended ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL8N44B01A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSEM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659000029","title":"BioStem Technologies Q2 EPS $(0.52), Sales $7.899M Down From $10.963M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2659000029","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659000029?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:30","pubTimestamp":1786566659,"startTime":"0","endTime":"0","summary":"BioStem Technologies (NASDAQ:BSEM) reported quarterly losses of $(0.52) per share.  The company reported $7.899 million in sales this quarter. This is a 27.95 percent decrease over sales of $10.963 million the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61159853/biostem-technologies-q2-eps-0-52-sales-7-899m-down-10-963m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"BioStem Technologies Q2 EPS $(0.52), Sales $7.899M Down From $10.963M YoY","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BSEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659684900","title":"BioStem Q2 FY26 GAAP Net Loss Widens to $9 Million; Revenue Rises 29% to $7.9 Million vs Q1","url":"https://stock-news.laohu8.com/highlight/detail?id=2659684900","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659684900?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:13","pubTimestamp":1786565583,"startTime":"0","endTime":"0","summary":"BioStem Q2 FY26 GAAP net loss widens to $9 million; revenue rises 29% to $7.9 million vs Q1BioStem posts Q2 2026 net revenue of USD 7.9 million, up 29% sequentially.GAAP swings to a net loss of USD 9 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL2wdNGw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00BKPKM429.USD","BSEM","BK4112","BCDF","IE00B3QW5Z07.USD","BK4588","IE00BGHQF748.EUR","LU2095319765.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","NDAQ","IE00BN0W2W23.USD","SG9999014039.USD","BK4007","LU0314104364.USD","SG9999014013.SGD","SG9999014021.USD","SG9999014005.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659042907","title":"Press Release: BioStem Technologies Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659042907","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659042907?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565100,"startTime":"0","endTime":"0","summary":"Generates 29% sequential revenue growth, increasing to $7.9 million;Raises full-year 2026 revenue guidanceUplists to Nasdaq Capital MarketPOMPANO BEACH, Fla., Aug. 12, 2026  -- BioStem Technologies, Inc. , a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today reported financial results for the second quarter ended June 30, 2026.Recent Corporate Highlights-- Completed the uplisting of the Company's common stock to the Nasdaq. -- Completed a $2.5 million private placement with the Company's first. representing sequential growth of 29% from $6.1 million in the first. -- Continued to scale the commercial organization, expanding the direct. sales force, integrating the CRM and ERP systems, and transitioning all. major group purchasing organization  agreements to broaden access. -- Issued eight new U.S. design patents covering fenestrated human placental","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","BK4232","BK4604","BK4555","BK4585","BK4099","BSEM","TM","BK4007","BK4588","R","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657626524","title":"BioStem Technologies to Begin Trading on NASDAQ Capital Market Aug. 7 Under BSEM Ticker","url":"https://stock-news.laohu8.com/highlight/detail?id=2657626524","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657626524?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:16","pubTimestamp":1786133780,"startTime":"0","endTime":"0","summary":"BioStem Technologies to begin trading on Nasdaq Capital Market Aug. 7 under BSEM tickerBioStem Technologies will move its common stock listing to the Nasdaq Capital Market from the OTC market.Trading ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL2PVGbN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSEM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657665136","title":"Biostem Technologies Announces NASDAQ Uplisting","url":"https://stock-news.laohu8.com/highlight/detail?id=2657665136","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657665136?lang=en_us&edition=fundamental","pubTime":"2026-08-07 05:38","pubTimestamp":1786052304,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nFWN4431J4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BSEM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650184077","title":"Biostem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission","url":"https://stock-news.laohu8.com/highlight/detail?id=2650184077","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650184077?lang=en_us&edition=fundamental","pubTime":"2026-07-10 19:00","pubTimestamp":1783681207,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nFWN43C0K8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BSEM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650184071","title":"Biostem Technologies - Shares to Continue Trading on Otc Under 'bsem' Until NASDAQ Uplisting","url":"https://stock-news.laohu8.com/highlight/detail?id=2650184071","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650184071?lang=en_us&edition=fundamental","pubTime":"2026-07-10 19:00","pubTimestamp":1783681207,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nFWN43C0K8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BSEM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649995943","title":"BioStem Technologies issued four U.S. design patents for allograft technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2649995943","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649995943?lang=en_us&edition=fundamental","pubTime":"2026-07-08 20:15","pubTimestamp":1783512941,"startTime":"0","endTime":"0","summary":"BioStem Technologies (BSEM) announced that the USPTO has issued four U.S. design patents covering the company’s proprietary fenestrated human place...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biostem-technologies-issued-four-u-s-design-patents-for-allograft-technology-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biostem-technologies-issued-four-u-s-design-patents-for-allograft-technology-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BSEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642464941","title":"BRIEF-Biostem Technologies Announces Appointment Of Three New Members To Its Board Of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2642464941","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642464941?lang=en_us&edition=fundamental","pubTime":"2026-06-09 19:02","pubTimestamp":1781002923,"startTime":"0","endTime":"0","summary":"BRIEF-Biostem Technologies Announces Appointment Of Three New Members To Its Board Of DirectorsJune 9 (Reuters) - Biostem Technologies Inc BSEM.PK:BIOSTEM TECHNOLOGIES ANNOUNCES APPOINTMENT OF THREE N","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nTUA1DXPTH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSEM","MTVA","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642464147","title":"Press Release: BioStem Technologies Announces Appointment of Three New Members to its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2642464147","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642464147?lang=en_us&edition=fundamental","pubTime":"2026-06-09 19:02","pubTimestamp":1781002920,"startTime":"0","endTime":"0","summary":"POMPANO BEACH, Fla., June 09, 2026  -- BioStem Technologies Inc. , a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced the appointment of Mark Glickman, Steven D. Sonenreich, and Rayna Lesser Hannaway to its Board of Directors, effective as of June 5, 2026. In connection with their appointment to the Board of Directors, Mr. Sonenreich has been appointed as a member of the Audit Committee and the Corporate Governance and Nominating Committee, Ms. Hannaway has been appointed as a member of the Audit Committee and the Corporate Governance and Nominating Committee and Mr. Glickman has been appointed as a member and as Chair of the Compensation Committee. Concurrently, the Company also announced that Thomas Dugan and Patrick Daly have resigned from the board, effective as of June 4, 2026. Following these changes, the Company's Board of Directors consists of seven members.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4555","BSEM","BK4588","BK4007","BK4022","BK4585","TM","BK4099","03160","BK4232","BK4604"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642346463","title":"Biostem Technologies Announces Appointment of Three New Members to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2642346463","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642346463?lang=en_us&edition=fundamental","pubTime":"2026-06-09 19:00","pubTimestamp":1781002801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nTUA1DXPTH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BSEM","MTVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637315024","title":"Biostem Technologies Announces $2.5 Million Private Placement Financing With Its First Institutional Investor","url":"https://stock-news.laohu8.com/highlight/detail?id=2637315024","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637315024?lang=en_us&edition=fundamental","pubTime":"2026-05-22 19:00","pubTimestamp":1779447600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nTUA98XHSQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BSEM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635031534","title":"BioStem Technologies price target lowered to $7 from $9 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2635031534","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635031534?lang=en_us&edition=fundamental","pubTime":"2026-05-16 01:08","pubTimestamp":1778864934,"startTime":"0","endTime":"0","summary":"H.C. Wainwright lowered the firm’s price target on BioStem Technologies (BSEM) to $7 from $9 and keeps a Buy rating on the shares. The firm said th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biostem-technologies-price-target-lowered-to-7-from-9-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biostem-technologies-price-target-lowered-to-7-from-9-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BSEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635729596","title":"Press Release: BioStem Technologies Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2635729596","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635729596?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:59","pubTimestamp":1778792340,"startTime":"0","endTime":"0","summary":"POMPANO BEACH, Fla., May 14, 2026  -- BioStem Technologies, Inc. , a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today reported financial results for the first quarter ended March 31, 2026.-- Generated net revenue of $6.1 million for the first quarter 2026. -- Progressed integration initiatives following the BioTissue assets. -- Expanded direct sales force to 35 representatives, up from 18 at the. -- Strengthened leadership team with appointment of Katherine Gorrell as. notes, with an aggregate principal amount of $3 million. Net revenue was $6.1 million, compared to $10.1 million in the fourth quarter of 2025 and $16.0 million in the first quarter of 2025. Revenue for the first quarter was primarily driven by Neox and Clarix product sales. Hospital revenue represented approximately 87% of total revenue, or $5.4 million, and physician office revenue contributed $0.8 million.Gross profit w","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSEM","BK4588","BK4099","TM","03160","BK4022","BK4555","BK4585","BK4007","BK4604","R","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635772542","title":"BioStem Technologies Q1 revenue falls 62% yr/yr","url":"https://stock-news.laohu8.com/highlight/detail?id=2635772542","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635772542?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:25","pubTimestamp":1778790325,"startTime":"0","endTime":"0","summary":"BioStem Technologies Q1 revenue falls 62% yr/yrOverviewRegenerative medicine firm's Q1 revenue fell sharply yr/yr after BioTissue asset acquisitionCompany posted Q1 net loss versus net income a year e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL1N41R1A6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BSEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635723381","title":"Biostem Technologies, Inc. Q1 EPS USD -0.52","url":"https://stock-news.laohu8.com/highlight/detail?id=2635723381","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635723381?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:05","pubTimestamp":1778789104,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nPLX33198C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BSEM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633193653","title":"Biostem Technologies initiated with a Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2633193653","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633193653?lang=en_us&edition=fundamental","pubTime":"2026-05-07 11:26","pubTimestamp":1778124401,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Swayampakula Ramakanth initiated coverage of Biostem Technologies (BSEM) with a Buy rating and $9 price target While the de...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biostem-technologies-initiated-with-a-buy-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biostem-technologies-initiated-with-a-buy-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BSEM"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":24,"code":"91000000","status":"200"}]}}